IRIS
BERARDI, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.542
EU - Europa 8.248
AS - Asia 4.137
SA - Sud America 872
AF - Africa 333
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 11
Totale 30.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.492
IT - Italia 1.350
UA - Ucraina 1.318
SG - Singapore 1.206
RU - Federazione Russa 1.175
IE - Irlanda 1.068
HK - Hong Kong 1.001
CN - Cina 882
DE - Germania 877
BR - Brasile 813
SE - Svezia 795
TR - Turchia 518
FI - Finlandia 466
DK - Danimarca 455
GB - Regno Unito 270
KR - Corea 254
CI - Costa d'Avorio 219
FR - Francia 206
IN - India 142
MA - Marocco 78
BE - Belgio 63
NL - Olanda 61
AT - Austria 38
AR - Argentina 24
JP - Giappone 23
PL - Polonia 23
CA - Canada 22
RO - Romania 21
CZ - Repubblica Ceca 16
BD - Bangladesh 15
EU - Europa 14
UZ - Uzbekistan 14
ZA - Sudafrica 14
MX - Messico 13
PK - Pakistan 13
AZ - Azerbaigian 11
EC - Ecuador 10
ES - Italia 10
IQ - Iraq 9
NZ - Nuova Zelanda 7
VE - Venezuela 7
CO - Colombia 6
TN - Tunisia 6
CH - Svizzera 5
GR - Grecia 5
KG - Kirghizistan 5
PE - Perù 5
AU - Australia 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
VN - Vietnam 4
BI - Burundi 3
BO - Bolivia 3
EG - Egitto 3
HN - Honduras 3
HR - Croazia 3
JO - Giordania 3
RS - Serbia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
ID - Indonesia 2
LK - Sri Lanka 2
NP - Nepal 2
PH - Filippine 2
SM - San Marino 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BT - Bhutan 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
Totale 30.157
Salva come PNG Salva come JPEG
Città #
Chandler 2.049
Jacksonville 1.509
Fairfield 1.491
Des Moines 1.175
Ashburn 1.115
Dublin 1.061
Hong Kong 996
Boardman 978
Wilmington 725
Woodbridge 665
Seattle 633
Singapore 603
Houston 578
New York 512
Ann Arbor 496
Cambridge 482
Lawrence 389
Princeton 389
San Mateo 365
Moscow 243
Centro 223
Abidjan 219
The Dalles 204
San Diego 185
Beijing 173
Munich 162
Helsinki 152
Turin 112
Washington 99
Pune 97
Los Angeles 94
London 82
Turku 80
Ancona 78
Dallas 64
Brussels 62
Milan 62
Guangzhou 61
Santa Clara 61
Shanghai 57
São Paulo 55
Marche 41
Falls Church 40
Nuremberg 40
Norwalk 37
Rome 35
Rio de Janeiro 32
Wuhan 31
Tolentino 27
Belo Horizonte 26
Kilburn 26
Chicago 23
Zhengzhou 22
Prescot 21
Redmond 21
Jiaxing 20
Vienna 20
Porto 19
Warsaw 18
Hangzhou 17
Izmir 17
Shenzhen 16
Wuxi 16
Chiaravalle 15
Macerata 15
San Francisco 15
Brasília 14
Olomouc 14
Xi'an 14
Visakhapatnam 13
Brasov 12
Campinas 12
Hounslow 12
Tashkent 12
Yiwu 12
Fayetteville 11
Salvador 11
Seoul 11
Tokyo 11
Amsterdam 10
Baku 10
Brooklyn 9
Chengdu 9
Chiswick 9
Ningbo 9
Pescara 9
Porto Alegre 9
Squinzano 9
Florence 8
Istanbul 8
Naples 8
Baghdad 7
Cantu 7
Curitiba 7
Johannesburg 7
New Bedfont 7
Phoenix 7
Qualiano 7
Recife 7
Secaucus 7
Totale 19.775
Salva come PNG Salva come JPEG
Nome #
The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer 241
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas 217
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy 190
Anemia may influence the outcome of patients undergoing neoadjuvant treatment for rectal cancer 185
Endometriosis-associated Clear Cell Carcinoma of the Abdominal Wall After Caesarean Section: A Case Report and Review of the Literature 178
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 142
The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis 136
Syndrome of inappropriate antidiuretic hormone secretion (Siadh): Optimal management 134
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients. 127
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 127
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 126
Are liver nested stromal epithelial tumors always low aggressive? 124
Squamous cell carcinoma of the lung: clinical criteria for treatment strategy 123
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 122
Optimal management of resected gastric cancer 120
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 120
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study 119
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 118
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 117
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 117
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study 117
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials 117
Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy. 114
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 114
Thymic Malignancies in the targeted terapies era 113
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 112
Metabolic phenotype of bladder cancer 112
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma. 111
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 111
Rossana Berardi, Mariangela Torniai, Agnese Savini, Silvia Rinaldi, Stefano Cascinu. Gastro-entero-pancreatic neuroendocrine tumors: is now time for a new approach? 110
Role of DCE-MR in predicting breast cancer subtypes. 110
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 108
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 108
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO) 106
Progress of molecular targeted therapies for advanced renal cell carcinoma. 106
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 105
Contrasting Digital Fake News in Health: an Interdisciplinary Approach 105
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 105
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study 104
Adjuvant treatment after surgical resection 104
Severe prognosis of signet-ring cell adenocarcinoma occurring in meckel’s diverticulum 103
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients 103
Seminoma Retroperitoneal Relapse 23 Years After Surgery 103
5-Fluorouracil pharmacogenomics: still rocking after all these years? 102
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 102
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 101
Lynphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. 101
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 101
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 99
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 99
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 99
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study 99
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 99
Pancreatic cancer: progress in cancer therapy. 98
Contrasting Fake News in Oncology: The First Declaration of Good Communication 98
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 97
Managing hyponatremia in lung cancer: latest evidence and clinical implications 97
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 97
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 96
Gender differences and outcome of melanoma patients 95
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 95
Electrolyte disorders in cancer patients: a systematic review 95
Medical treatment for cholangiocarcinoma 95
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes 95
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 95
New target therapies in advanced pancreatic cancer. 94
Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy. 94
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 94
Modifications of taste sensitivity in cancer patients: a method for the evaluations of dysgeusia 94
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 94
Randomized active-controlled phase 2 study of Denosumab efficacy and safety in patients with breast cancer-related bone metastases. 93
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 93
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 93
Gender Differences and Outcomes in Melanoma Patients 93
Benefits and limitations of a multidisciplinary approach in cancer patient management 93
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 92
A cost-benefit analysis of chemotherapy for gastric cancer. 91
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 91
Hyponatremia in cancer patients: Time for a new approach 91
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 91
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 91
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 90
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 90
Systemic treatment for lung carcinoids: from bench to bedside 90
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 90
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 90
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study 90
Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib 90
Extended efficacy and safety Denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy. 90
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2. 89
Evaluation of Multifocality and multicentricity with Breast Magnetic Resonance Imaging in each breast cancer subtype 89
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 89
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 89
Social distress among Medical Oncologists and other Health Care Professionals during the first wave of COVID-19 pandemic in Italy 89
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 88
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 88
High CTLA-4 expression correlates with poor prognosis in thymoma patients 88
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 88
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 87
Chromium Exposure and Germinal Embryonal Carcinoma: first Two Cases and Review of the Literature 86
Totale 10.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 181.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020441 0 0 0 0 0 0 0 0 0 0 0 441
2020/20215.907 292 547 796 342 738 391 506 437 490 454 569 345
2021/20223.059 169 642 78 98 42 224 125 209 303 208 329 632
2022/20236.361 520 648 404 531 338 1.619 2 325 1.359 58 412 145
2023/20243.665 581 83 234 409 575 879 52 132 10 131 51 528
2024/20257.529 852 755 371 158 339 357 692 323 1.952 659 824 247
Totale 31.104